Literature DB >> 9291859

Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities.

M Takahashi1, J Okada, H Kondo.   

Abstract

We report six cases that were positive for anti-centromere antibodies, with ulcer and gangrene in the extremities but mild or no skin thickening. The patients were five women and one man, and the mean age at onset of gangrene was 56 yr. Raynaud's phenomenon was found in five patients and calcinosis cutis in two patients. Three patients did not satisfy the criteria for systemic sclerosis and CREST syndrome in this study. Ulcer and gangrene occurred in the fingers in three patients, and in the fingers and toes in two patients. The gangrene was refractory to treatment, and amputation of fingers or toes was inevitable in five patients. Regardless of cutaneous lesion, the presence of anti-centromere antibodies may cause the same pathological presentation of vascular damage as seen in systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291859     DOI: 10.1093/rheumatology/36.8.889

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  4 in total

1.  Radiological hand involvement in systemic sclerosis.

Authors:  J Avouac; H Guerini; J Wipff; N Assous; A Chevrot; A Kahan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

2.  Digital gangrene associated with anticentromere antibodies: a case report.

Authors:  Lauren Bolster; Regina M Taylor-Gjevre; Bindu Nair; John A Gjevre
Journal:  J Med Case Rep       Date:  2010-06-22

Review 3.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980

4.  Digital gangrene associated with anticentromere antibodies.

Authors:  Mary Grace; Es Dhanesh
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.